
Dr. Martin van Eickels
Angestellt, Director Global Medical Affairs, Bayer Healthcare
Berlin, Germany
Werdegang
Berufserfahrung von Martin van Eickels
- Current 16 years and 3 months, since Apr 2010
Director Global Medical Affairs
Bayer Healthcare
Director Global Medical Affairs Thrombosis
- 3 years and 11 months, Apr 2006 - Feb 2010
Clinical Research Director
sanofi-aventis
Clinical Research Director responsible for several Phase I - III programs in the cardiovascular field, including the conduct, reporting, publication of the ATHENA trial and the associated world wide registration activities, which led to the successful launch of Dronedarone (MULTAQ(TM)) in numerous countries worldwide. Development of the LCM program for Dronedarone (MULTAQ(TM)) including the design of the PALLAS study, planning to include more than 11000 patients with permanent atrial fibrillation.
Ausbildung von Martin van Eickels
- 8 months, Sep 1994 - Apr 1995
Medizin
Tufts University Boston, USA
DAAD Stipendium BMEP Program
- 1 year, Aug 1991 - Jul 1992
Medizin
Universitat de Valencia Spanien
ERASMUS Stipendium
- 7 years and 4 months, Apr 1988 - Jul 1995
Medizin
Rheinische Friedrich-Wilhelms-Universität Bonn
Sprachen
German
English
Spanish
French
